Table 1.
LDLT recipient data | AKI group N=21 | Non-AKI group N=79 | *p≤0.05 |
---|---|---|---|
| |||
Pre-operative Variables
| |||
Patient age (years) | 52.4±11.9 | 52.8±12.1 | 0.895 |
Patient sex (male) | 13 (61.9%) | 40 (50.6%) | 0.358 |
Patient weight (kg) | 80.1±17.7 | 79.5±16.8 | 0.868 |
Patient race (Caucasian) | 19 (90.5%) | 75 (94.9%) | 0.273 |
MELD score | 14 [10; 18] | 12 [9; 15] | 0.086 |
Child score | 8 [8; 11] | 8 [7; 10] | 0.166 |
Serum creatinine (mg/dl) | 0.9 [0.7; 1.1] | 0.9 [0.7; 1.1] | 0.905 |
Modification of Diet in Renal Disease (MDRD) formula | 90.7±41.2 | 85.1±30.2 | 0.486 |
eGFR (<60 ml/min/1.73 m2) | 4 (19%) | 15 (19%) | 0.995 |
Pre-existing diabetes mellitus | 7 (33.3%) | 21 (26.6%) | 0.54 |
Pre-existing coronary artery disease | 1 (4.8%) | 5 (6.3%) | 0.788 |
| |||
Intra-operative Variables | |||
| |||
Total operative time (h) | 7.7 [7.1; 10] | 7.9 [6.8; 8.9] | 0.939 |
Cold ischemic time (min) | 135 [109; 166] | 118 [96; 147] | 0.238 |
Warm ischemic time (min) | 31 [26; 42] | 32 [30; 38] | 0.703 |
Veno-veno bypass use | 18 (90%) | 76 (98.7%) | 0.045* |
Methylene blue use | 14 (70%) | 49 (63.6%) | 0.595 |
Aprotinin use | 1 (5%) | 2 (2.6%) | 0.58 |
Post-reperfusion syndrome | 6 (28.6%) | 6 (7.6%) | 0.009* |
Crystalloid (liters) | 5.8±2.6 | 5.3±1.9 | 0.392 |
Colloid (liters) | 2.8±1 | 2.6±1.2 | 0.528 |
Packed red cell (units) | 5 [3; 8] | 4 [2; 7] | 0.114 |
Fresh frozen plasma (units) | 2 [0; 4] | 2 [0; 4] | 0.321 |
Platelets (units) | 1 [0.5; 2] | 0 [0; 1] | 0.014* |
Cryoprecipitate (units) | 0 [0; 0] | 0 [0; 0] | 0.223 |
| |||
Donor Characteristics | |||
| |||
Donor race (Caucasian) | 17 (81%) | 73 (92.4%) | 0.281 |
Donor age (years) | 39±11.9 | 36.9±10.7 | 0.432 |
Donor height (cm) | 1.71±11 | 1.71±11 | 0.907 |
Donor weight (kg) | 73.3±16.9 | 79.5±15.8 | 0.121 |